Physician profile
R Hill
NPI 1184835605
$2,693.06
in general payments reported to CMS, 2019-2025
15 companies · $537 in 2025
The $537 reported for 2025 was more than what 80% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $473 · 2021: $513 · 2022: $608 · 2023: $136 · 2024: $113 · 2025: $537.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $752 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $751.76 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,640.23 | 2019-2025 | Scopis Ent, Xpress Loprofile, Clarifix Cryotherapy Device |
| Genzyme Corporation | $325.32 | 2019-2025 | |
| Merz North America, INC. | $157.78 | 2020-2021 | |
| Aerin Medical INC. | $148.14 | 2020-2025 | |
| Regeneron Healthcare Solutions, INC. | $109.72 | 2019-2025 | Dupixent |
| Intersect Ent, INC. | $70.84 | 2021 | |
| Medtronic, INC. | $57.11 | 2023-2025 | Propel |
| Acclarent, INC | $55.49 | 2019-2022 | |
| Amgen INC. | $34.00 | 2025 | |
| Olympus America INC. | $19.24 | 2019 | |
| Optinose US, INC. | $17.08 | 2024 | |
| Heron Therapeutics, INC. | $15.85 | 2022 | |
| Hikma Pharmaceuticals USA | $14.95 | 2025 | Ryaltris |
| Smith+Nephew, INC. | $14.71 | 2019 | |
| Abbvie INC. | $12.60 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw R Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.